Search - tctmd.com

Displaying 381 - 400 of 1388

Sort: Relevancy | Date

Presentation TCT 2016

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Antonio Enrique Dager

October 30, 2016

Presentation TCT 2016

TVA Medical Approach

Presenter: Mitchell W. Krucoff, Katherine Kumar

October 30, 2016

Presentation TCT 2016

Updated MitraClip Outcomes From European Registries

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben

October 30, 2016

Presentation TCT 2016

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies)

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

Updated MitraClip Outcomes From the STS TVT Registry

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Gorav Ailawadi

October 30, 2016

Presentation TCT 2016

Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR

Presenter: A. Pieter Kappetein, Allan Schwartz, Howard C. Herrmann

October 30, 2016

Presentation TCT 2016

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Chris Meduri

October 30, 2016

Presentation TCT 2016

Early and Late Results With the Occlutech LAA Occluder (and Future studies)

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Horst Sievert

October 30, 2016

Presentation TCT 2016

MitraClip: 40,000 Cases Worldwide: What We Know and What We Dont

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Ted Feldman

October 30, 2016

Presentation TCT 2016

Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis

Presenter: A. Pieter Kappetein, Allan Schwartz, Philippe Pibarot

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Early Insights from Industry

Presenter: Charles J. Davidson, Nicole Ibrahim, Dan Mans

October 30, 2016

Presentation TCT 2016

TCT 1611: Trialign: Transcatheter Repair of the Tricuspid Valve

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Nadira Hamid

October 30, 2016

Presentation TCT 2016

Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies

Presenter: Vivek Y. Reddy, Steven J. Yakubov, Apostolos Tzikas

October 30, 2016

Presentation TCT 2016

Transcatheter Valve-in-Valve Therapy: Clinical and Technical Pearls

Presenter: A. Pieter Kappetein, Allan Schwartz, Vinayak Bapat

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Presenter: Charles J. Davidson, Nicole Ibrahim, Paul Sorajja

October 30, 2016

Presentation TCT 2016

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Presenter: Michael J. Mack, Francesco Maisano, Marco Moscarelli

October 30, 2016

Presentation TCT 2016

Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies

Presenter: A. Pieter Kappetein, Allan Schwartz, Danny Dvir

October 30, 2016

Presentation TCT 2016

How Good Can Surgical Outcomes Be in Secondary MR?

Presenter: Michael J. Mack, Francesco Maisano, Michael Argenziano

October 30, 2016

Presentation TCT 2016

TCT 1600: Minimally Invasive Mitral Valve Replacement With Sapien S3 Valve in a Patient With Severe MAC

Presenter: Henrique B. Ribeiro, Dimytri Alexandre Siqueira, Deborah Tabachnick

October 30, 2016

Presentation TCT 2016

Appropriate Use Criteria of LAA Closure Devices: PMDAs View

Presenter: Mitchell W. Krucoff, Shigeru Saito, Sara Takahashi

October 30, 2016

Advertisement

Case 4: A Patient With Severe Aortic Valve Stenosis and Intermediate Surgical Risk. How Did I Treat It?

TVA Medical Approach

Updated MitraClip Outcomes From European Registries

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies)

Updated MitraClip Outcomes From the STS TVT Registry

Low-Flow Aortic Stenosis: Clinical Outcomes After TAVR

TCT 1559: TMVR Using a Fully Repositionable (LOTUS) Valve in a Patient With Severe MAC, Septal Hypertrophy, Left Main Disease, and Severe Aortic Stenosis: Importance of Preprocedural Planning

Early and Late Results With the Occlutech LAA Occluder (and Future studies)

MitraClip: 40,000 Cases Worldwide: What We Know and What We Dont

Low-Flow Aortic Stenosis: Pathophysiology, Syndrome Classification, and Prognosis

TMVR Clinical Trial Design: Early Insights from Industry

TCT 1611: Trialign: Transcatheter Repair of the Tricuspid Valve

Synthesis of ACP/Amulet Studies in Anticoagulated Indicated and Contra-indicated Patients: Certainties, Data Gaps, and Future Studies

Transcatheter Valve-in-Valve Therapy: Clinical and Technical Pearls

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies

How Good Can Surgical Outcomes Be in Secondary MR?

TCT 1600: Minimally Invasive Mitral Valve Replacement With Sapien S3 Valve in a Patient With Severe MAC

Appropriate Use Criteria of LAA Closure Devices: PMDAs View

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content